申请人:Rgenix, Inc.
公开号:US10308597B2
公开(公告)日:2019-06-04
This invention relates to compounds that inhibit creatine transport and/or creatine kinase, pharmaceutical compositions including such compounds, and methods of utilizing such compounds and compositions for the treatment of cancer.
本发明涉及抑制肌酸转运和/或肌酸激酶的化合物、包括此类化合物的药物组合物,以及利用此类化合物和组合物治疗癌症的方法。